Lethbridge Research Centre, Agriculture and Agri-Food Canada, Lethbridge, Alberta, Canada.
Department of Ruminant Production, IRTA, Caldes de Montbui, Barcelona, Spain.
PLoS One. 2019 May 24;14(5):e0217518. doi: 10.1371/journal.pone.0217518. eCollection 2019.
Oral meloxicam is labelled for reducing pain and inflammation associated with castration in cattle in Canada, however, subcutaneous meloxicam is only labelled for pain associated with dis-budding and abdominal surgery. The aim of this project was to determine the pharmacokinetic profile of oral (PO; 1.0 mg/kg BW) and subcutaneous meloxicam (SC; 0.5 mg/kg BW), and to assess the effect of meloxicam on physiological and behavioural indicators of pain associated with knife castration in 7-8 month old calves. Twenty-three Angus crossbred beef calves (328 ± 4.4 kg BW) were randomly assigned to two treatments: PO n = 12 or SC n = 11 administration of meloxicam immediately before knife castration. Physiological parameters included salivary and hair cortisol, substance P, haptoglobin, serum amyloid-A, weight, complete blood count, scrotal and rectal temperature. Behavioural parameters included standing and lying behaviour, pen behaviour and feeding behaviour. Data were analyzed using PROC GLIMMIX (SAS), with repeated measures using mixed procedures including treatment as a fixed effect and animal and pen as a random effect. The pharmacokinetic profile of the drug including area under the curve, volume of distribution and clearance was greater (P < 0.05) in PO than SC calves. After surgery, substance P concentrations, white blood cell counts (WBC), weight and lying duration were greater (P < 0.05) in PO than SC calves, while scrotal circumference was lower (P < 0.05) in PO calves than SC calves. Although statistical differences were observed for pharmacokinetic, physiological and behavioural parameters differences were small and may lack biological relevance.
口腔美洛昔康在加拿大被标记为用于减少去势引起的牛的疼痛和炎症,然而,皮下美洛昔康仅标记为与去角和腹部手术相关的疼痛。本项目的目的是确定口服(PO;1.0mg/kg BW)和皮下美洛昔康(SC;0.5mg/kg BW)的药代动力学特征,并评估美洛昔康对 7-8 月龄小牛去势引起的疼痛的生理和行为指标的影响。23 头安格斯杂交肉牛(328±4.4kg BW)随机分为两组:PO 组 n = 12 或 SC 组 n = 11,在去势前立即给予美洛昔康。生理参数包括唾液和毛发皮质醇、P 物质、触珠蛋白、血清淀粉样蛋白 A、体重、全血计数、阴囊和直肠温度。行为参数包括站立和躺卧行为、围栏行为和进食行为。使用 PROC GLIMMIX(SAS)进行数据分析,使用混合程序进行重复测量,包括作为固定效应的处理和动物和围栏作为随机效应。药物的药代动力学特征,包括曲线下面积、分布容积和清除率,在 PO 组比 SC 组更高(P<0.05)。手术后,PO 组的 P 物质浓度、白细胞计数(WBC)、体重和躺卧时间大于 SC 组(P<0.05),而 PO 组的阴囊周长小于 SC 组(P<0.05)。尽管在药代动力学、生理和行为参数方面观察到了统计学差异,但差异较小,可能缺乏生物学相关性。